Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 873-879, 2003; 10.1373/49.6.873
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Labugger, R.
Right arrow Articles by Van Eyk, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labugger, R.
Right arrow Articles by Van Eyk, J. E.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2003;49:873-879.)
© 2003 American Association for Clinical Chemistry, Inc.

Strategy for Analysis of Cardiac Troponins in Biological Samples with a Combination of Affinity Chromatography and Mass Spectrometry

Ralf Labugger1,2, Jeremy A. Simpson1,2, Michelle Quick1, Heather A. Brown1, Christine E. Collier2,4, Irina Neverova1 and Jennifer E. Van Eyk1,3,a

Departments of
1 Physiology,
2 Pathology, and
3 Biochemistry, Queen’s University, Kingston, Ontario, K7L 3N6 Canada
4 Kingston General Hospital, Kingston, Ontario, K7L 3N6 Canada.

aAddress correspondence to this author at: Rm 429, Botterell Hall, Department of Physiology, Queen’s University, Kingston, Ontario, K7L 3N6 Canada. Fax 613-533-6880; e-mail jve1{at}post.queensu.ca.

Background: Cardiac troponins are modified during ischemic injury and are found as a heterogeneous mixture in blood of patients with cardiovascular diseases. We present a strategy to isolate cardiac troponins from human biological material, by use of affinity chromatography, and to provide samples ready for direct analysis by mass spectrometry.

Methods: Cardiac troponins were isolated from human left ventricular tissue by affinity chromatography. Isolated troponins were either eluted and analyzed by Western blot or enzymatically digested while bound to affinity beads. The resulting peptide mixture was subjected to mass spectrometry for protein identification and characterization. The same method was used to analyze serum from patients with acute myocardial infarction (AMI).

Results: Affinity chromatography with antibodies specific for one cardiac troponin subunit facilitated the isolation of the entire cardiac troponin complex from myocardial tissue. The three different proteases used for enzymatic digestion increased the total protein amino acid sequence coverage by mass spectrometry for the three cardiac troponin subunits. Combined amino acid sequence coverages for cardiac troponin I, T, and C (cTnI, cTnT, cTnC) were 54%, 48%, and 40%, respectively. To simulate matrix effects on the affinity chromatography–mass spectrometry approach, we diluted tissue homogenate in cardiac troponin-free serum. Sequence coverages in this case were 44%, 41%, and 19%, respectively. Finally, affinity chromatography–mass spectrometry analysis of AMI serum revealed the presence of cardiac troponins in a wide variety of its free and/or complexed subunits, including the binary cTnI-cTnC and cTnI-cTnC-cTnT complexes.

Conclusions: Affinity chromatography–mass spectrometry allows the extraction and analysis of cardiac troponins from biological samples in their natural forms. We were, for the first time, able to directly confirm the presence of cardiac troponin complexes in human serum after AMI. This approach could assist in more personalized risk stratification as well as the search for reference materials for cardiac troponin diagnostics.




The following articles in journals at HighWire Press have cited this article:


Home page
 Mol. Cell. ProteomicsHome page
M. Fonovic, S. H. L. Verhelst, M. T. Sorum, and M. Bogyo
Proteomics Evaluation of Chemically Cleavable Activity-based Probes
Mol. Cell. Proteomics, October 1, 2007; 6(10): 1761 - 1770.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. L. Gundry and J. E. Van Eyk
Unraveling the Complexity of Circulating Forms of Brain Natriuretic Peptide
Clin. Chem., July 1, 2007; 53(7): 1181 - 1182.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. L. Hortin, S. A. Jortani, J. C. Ritchie Jr, R. Valdes Jr, and D. W. Chan
Proteomics: A New Diagnostic Frontier
Clin. Chem., July 1, 2006; 52(7): 1218 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
L. Anderson
Candidate-based proteomics in the search for biomarkers of cardiovascular disease
J. Physiol., February 15, 2005; 563(1): 23 - 60.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.